Novartis India has announced the acquisition of Pfizer's hypertension drug Minipress for ₹1250 crore, aiming to enhance its product portfolio while Pfizer navigates sales declines in the wake of COVID ...

Piyush Goyal calls for regulatory alignment with developed countries to boost investment and innovation in India's pharmaceutical industry.

RPG Life Sciences plans to invest Rs 500 crore over the next year to enhance its manufacturing and Active Pharmaceutical Ingredients (API) capabilities, targeting significant growth in revenue and ...

Medical experts caution consumers about the use of experimental injectable peptides for weight loss and anti-aging, emphasizing the importance of safety and regulation, especially amidst rising ...

The European Medicines Agency reviews injectable iron medicines due to concerns about low phosphate levels and potential bone disorders. The assessment follows reports of serious adverse effects, ...

Fosun Pharma reduces its stake in Gland Pharma, selling 4.5% through block deals on BSE, attracting several major investors ...

Cipla has entered a licensing agreement to market Qil2107, a biosimilar of Keytruda in the US. The partnership aims to ...

India's drug regulator has flagged a batch of the widely used rabies vaccine Abhayrab as substandard, prompting ...

Novartis' experimental heart drug pelacarsen missed key goals in a late-stage trial, leading to a significant drop in shares for both Novartis and partner Ionis Pharmaceuticals. This setback raises ...

Novartis India is set to enhance its growth strategy with therapy-aligned acquisitions while expanding its reach in Tier 2 and Tier 3 markets. Focus areas include pain management, wellness, and ...

Lupin Ltd has received USFDA approval for Modafinil tablets (100 mg and 200 mg) used to treat excessive sleepiness associated ...

The Indian pharmaceutical industry opposes a new regulatory proposal that holds drug manufacturers accountable for ...